Skip to main content
logo
Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.540
+0.090 (6.21%)
At close: Jan 6, 2026, 4:00 PM EST
1.560
+0.020 (1.30%)
After-hours: Jan 6, 2026, 7:58 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '20 Dec '13 Dec '12
Novel Gene and Cell Therapies, Biologics and Vaccines
4.05M
Log In
Log In
Log In
Log In
Novel Gene and Cell Therapies, Biologics and Vaccines Growth
-32.82%
Log In
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '20 Dec '13 Dec '12
United States
4.05M
Log In
Log In
Log In
Log In
United States Growth
-32.82%
Log In
Log In
Log In
Log In
Israel
-
Log In
Log In
Log In
Log In
Israel Growth
-
Log In
Log In
Log In
Log In